You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

AGRYLIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Agrylin, and what generic alternatives are available?

Agrylin is a drug marketed by Takeda Pharms Usa and is included in one NDA.

The generic ingredient in AGRYLIN is anagrelide hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the anagrelide hydrochloride profile page.

Drug patent expirations by year for AGRYLIN
Drug Prices for AGRYLIN

See drug prices for AGRYLIN

Recent Clinical Trials for AGRYLIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ShirePhase 3
Mylan PharmaceuticalsPhase 1

See all AGRYLIN clinical trials

Pharmacology for AGRYLIN

US Patents and Regulatory Information for AGRYLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa AGRYLIN anagrelide hydrochloride CAPSULE;ORAL 020333-001 Mar 14, 1997 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa AGRYLIN anagrelide hydrochloride CAPSULE;ORAL 020333-002 Mar 14, 1997 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.